EWTX logo

Edgewise Therapeutics (EWTX) Cash From Investing

Annual CFI

-$184.66 M
-$287.54 M-279.48%

December 31, 2024


Summary


Performance

EWTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWTXcash flowmetrics:

Quarterly CFI

$20.92 M
-$4.44 M-17.51%

December 31, 2024


Summary


Performance

EWTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWTXcash flowmetrics:

TTM CFI

-$184.66 M
-$6.06 M-3.39%

December 31, 2024


Summary


Performance

EWTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEWTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EWTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-279.5%-17.5%-3.4%
3 y3 years+23.8%-10.7%-10000.0%
5 y5 years-10000.0%-10.7%-10000.0%

EWTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-279.5%+23.8%-57.3%+107.8%-279.5%+23.8%
5 y5-year-279.5%+23.8%-57.3%+107.8%-279.5%+34.2%
alltimeall time-279.5%+23.8%-57.3%+107.8%-279.5%+34.2%

Edgewise Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$184.66 M(-279.5%)
$20.92 M(-17.5%)
-$184.66 M(+3.4%)
Sep 2024
-
$25.36 M(-32.1%)
-$178.59 M(-1.1%)
Jun 2024
-
$37.37 M(-113.9%)
-$180.54 M(-15.8%)
Mar 2024
-
-$268.31 M(-1094.4%)
-$214.46 M(-308.4%)
Dec 2023
$102.89 M(-245.8%)
$26.98 M(+15.2%)
$102.89 M(>+9900.0%)
Sep 2023
-
$23.42 M(+580.4%)
$307.00 K(-100.6%)
Jun 2023
-
$3.44 M(-93.0%)
-$49.43 M(-6.6%)
Mar 2023
-
$49.04 M(-164.9%)
-$52.92 M(-25.0%)
Dec 2022
-$70.58 M
-$75.60 M(+187.2%)
-$70.58 M(-468.7%)
Sep 2022
-
-$26.32 M(>+9900.0%)
$19.14 M(+38.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$46.00 K(-100.1%)
$13.85 M(-109.5%)
Mar 2022
-
$31.39 M(+122.3%)
-$146.07 M(-39.7%)
Dec 2021
-$242.23 M(+893.5%)
$14.12 M(-144.7%)
-$242.23 M(-13.7%)
Sep 2021
-
-$31.61 M(-80.2%)
-$280.53 M(+12.7%)
Jun 2021
-
-$159.97 M(+147.0%)
-$248.92 M(+179.2%)
Mar 2021
-
-$64.77 M(+167.9%)
-$89.14 M(+265.6%)
Dec 2020
-$24.38 M(>+9900.0%)
-$24.18 M(>+9900.0%)
-$24.38 M(>+9900.0%)
Sep 2020
-
-$6000.00(-96.8%)
-$203.00 K(+3.0%)
Jun 2020
-
-$188.00 K(+1988.9%)
-$197.00 K(+2088.9%)
Mar 2020
-
-$9000.00
-$9000.00
Dec 2019
-$180.00 K
-
-

FAQ

  • What is Edgewise Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual CFI year-on-year change?
  • What is Edgewise Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly CFI year-on-year change?
  • What is Edgewise Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Edgewise Therapeutics?
  • What is Edgewise Therapeutics TTM CFI year-on-year change?

What is Edgewise Therapeutics annual cash flow from investing activities?

The current annual CFI of EWTX is -$184.66 M

What is the all time high annual CFI for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual cash flow from investing activities is $102.89 M

What is Edgewise Therapeutics annual CFI year-on-year change?

Over the past year, EWTX annual cash flow from investing activities has changed by -$287.54 M (-279.48%)

What is Edgewise Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of EWTX is $20.92 M

What is the all time high quarterly CFI for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly cash flow from investing activities is $49.04 M

What is Edgewise Therapeutics quarterly CFI year-on-year change?

Over the past year, EWTX quarterly cash flow from investing activities has changed by -$4.44 M (-17.51%)

What is Edgewise Therapeutics TTM cash flow from investing activities?

The current TTM CFI of EWTX is -$184.66 M

What is the all time high TTM CFI for Edgewise Therapeutics?

Edgewise Therapeutics all-time high TTM cash flow from investing activities is $102.89 M

What is Edgewise Therapeutics TTM CFI year-on-year change?

Over the past year, EWTX TTM cash flow from investing activities has changed by -$6.06 M (-3.39%)